Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

527 Press Releases
DateTitleCompany
11 Oct 12 Inlyta®?(axitinib) launched in the UK for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine Pfizer Ltd
10 Oct 12 New Report Reveals Programs That Promote Healthy Ageing Can Help Reduce Rising Health Costs1 Pfizer Inc.,
Published by
Business Wire
04 Oct 12 Pfizer Announces Top-Line Results Of Prevenar 13® Phase 3 Trial In Adults 18 To 49 Years Of Age Pfizer Inc.,
Published by
Business Wire
21 Sep 12 Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
21 Sep 12 ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation Pfizer Inc.,
Published by
Business Wire
18 Sep 12 Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting Pfizer Inc.,
Published by
Business Wire
17 Sep 12 Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress Pfizer,
Published by
Business Wire
13 Sep 12 Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd. Pfizer Inc.,
Published by
Business Wire
11 Sep 12 World Health Organization Grants Expansion To The Prequalification For Prevenar 13 To Include Adults 50 Years Of Age And Older Pfizer Inc.,
Published by
Business Wire
07 Sep 12 Pfizer Settles Patent Litigation with Mylan Covering Detrol LA® Pfizer Inc.,
Published by
Business Wire
05 Sep 12 U.S. Food and Drug Administration Approves BOSULIF® (bosutinib) for Patients with Previously Treated Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML) Pfizer Inc.,
Published by
Business Wire
04 Sep 12 Pfizer Receives EU Marketing Authorization for INLYTA® (Axitinib) Pfizer Inc.,
Published by
Business Wire
31 Aug 12 Spiriva® HandiHaler® (tiotropium bromide inhalation powder) and COPD Data to be Presented at the 2012 European Respiratory Society (ERS) Congress Pfizer Inc,
Published by
Business Wire
28 Aug 12 Inspra significantly reduces risk of recurrent heart failure hospitalization Pfizer
28 Aug 12 Pfizer Announces Conclusion of Consent Solicitation For $22.5 Million of Debt Pfizer Inc.,
Published by
Business Wire
24 Aug 12 Pfizer Announces Successful Consent Solicitation Results For Three Series Of Debt Pfizer Inc.,
Published by
Business Wire
21 Aug 12 U.S. Food And Drug Administration Extends Action Date For Tofacitinib New Drug Application By Three Months Pfizer Inc.,
Published by
Business Wire
16 Aug 12 Pfizer Commences Consent Solicitation for Amendments to Pharmacia Indentures Pfizer Inc.,
Published by
Business Wire
14 Aug 12 Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium Pfizer Inc.,
Published by
Business Wire
13 Aug 12 Zoetis™ Files IPO Registration Statement Pfizer Inc.,
Published by
Business Wire
10 Aug 12 Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc.,
Published by
Business Wire
07 Aug 12 Pfizer Announces Resolutions with DOJ and SEC Related to Certain International Operations Pfizer Inc.,
Published by
Business Wire
07 Aug 12 SIGNIFICANTLY MORE PATIENTS WHO USE CHAMPIX?® (varenicline) ARE STILL SMOKE FREE AFTER ONE YEAR COMPARED WITH THOSE WHO USE NRT PATCH AND COMBINATION NRT1 Pfizer
07 Aug 12 Pfizer Announces Co-Primary Clinical Endpoints Not Met In Second Phase 3 Bapineuzumab Study In Mild-To-Moderate Alzheimer’s Disease Patients Who Do Not Carry The Apoe4 Genotype Pfizer Inc.,
Published by
Business Wire
07 Aug 12 Summertime Shines a Light on the Need for Vitamin D Pfizer,
Published by
Business Wire
03 Aug 12 Study Shows Toviaz Is Effective In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder After Suboptimal Response To Detrol LA Pfizer Inc.,
Published by
Business Wire
31 Jul 12 Pfizer Announces Positive Top-Line Results From The ORAL Start Phase 3 Study Of Tofacitinib In Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
31 Jul 12 Pfizer supports the use of Prevenar 13® as an important option to prevent Pfizer
31 Jul 12 Pfizer Reports Second-Quarter 2012 Results Pfizer Inc.,
Published by
Business Wire
24 Jul 12 Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab Phase 3 Program Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.